StockWatch
·

GUJARAT STATE FERTILIZERS & CHEMICALS LTD. Q2 FY27 Results

GSFCQ2 FY27 Results
Filing
Result:Weak· Market: Flat#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: None

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue4.7K32.3%48.7%
Total Income4.9K35.8%47.5%
Expenditure4.7K36.8%60.9%
PBT240.4719.0%43.7%
Net Profit200.2426.3%38.2%
OPM2.95%3.54pp7.61pp
NPM4.08%0.30pp5.65pp
EPS5.0226.1%38.3%
View full financials

Core profit metric (adjusted net profit) fell 38.2% YoY and consolidated NPM collapsed to 4.08% from 9.73% as the Fertilizer Products segment PBT crashed 93% on a mix shift toward low-margin traded stock-in-trade, so the 48.7% revenue growth is low-quality and does not offset the earnings deterioration.

GSFC · Q2 FY-2027 · THE VERDICT

Record Revenue, Subsidy Roulette: GSFC's Margin Crisis Deepens

Revenue jumped 49% to a record ₹4,741 Crore, but net profit fell 38% to ₹200 Crore. The culprit: a 92% collapse in fertilizer segment EBIT due to raw material shocks. Management now explicitly depends on pending government subsidy rates — a cliff with no timeline.

07 Nov 2026 · 6 min read
Reported Revenue

₹4,741 Cr

+48.7% YoY, record Q2

Reported PAT

₹200 Cr

-38.2% YoY

Fertilizer EBIT

₹17 Cr

vs ₹224 Cr prior year (−92%)

Industrial EBIT

₹66 Cr

vs ₹54 Cr prior year (+22%)

On the surface, GSFC delivered a stellar quarter: revenue hit a record ₹4,741 Crore, up 49% year-over-year. But the income statement tells a different story. Net profit fell 38% to ₹200 Crore despite that revenue growth. The gap is the story of Q2 — and the gap is margin compression so severe it has unmasked a structural subsidy dependency.

Where the profit went

Fertilizer segment EBIT, the company's core, collapsed 92% from ₹224 Crore in Q2 FY26 to just ₹17 Crore in Q2 FY27. The driver was a raw material shock of stunning magnitude: sulfur costs spiked 327%, natural gas 62%. With fertilizer prices regulated by government (especially DAP and urea), the company had no pricing power to offset these cost surges. Operating margins — before subsidies — effectively vanished.

Industrial Products, by contrast, thrived. The caprolactam-nylon chain benefited from a 66% widening in the capro-benzene spread (from USD 512/MT to USD 849/MT), lifting IP segment EBIT to ₹66 Crore (+22% sequentially). This is real strength, but it is insufficient arithmetic: IP's ₹66 Crore, even at peak performance, cannot offset a ₹207 Crore year-on-year EBIT decline in fertilizers. The industrial segment is now 33% of consolidated EBIT — helpful, but not healing.

The net result: OPM compressed to 3.0% from prior levels, NPM to 4.1%. The company is running at wafer-thin profitability, propped up by subsidy receivables of ₹3,400 Crore that remain pending (P&K subsidy received through September, urea through mid-October; the balance awaits future government disbursement).

EBIT, ₹ Crore
083.63167.25250.88224Fert. Q2'2617Fert. Q2'2754IP Q2'2666IP Q2'27
Fertilizer EBIT crater (−92%) only partially offset by Industrial Products strength (+22%).

Management claims vs. what holds up

Earnings call claims graded against reported results

Sales up 49% YoY on consolidated basis

Supported

Actual 48.7% YoY growth; matches

PAT reduced by 38% YoY despite revenue growth

Supported

Actual −38.2% YoY; exact match

Fertilizer EBIT compressed to ₹17 Cr from ₹224 Cr

Supported

92% segment decline; severity confirmed

Industrial Products EBIT up ₹12 Crore to ₹66 Crore

Supported

₹54 Cr → ₹66 Cr = +22% growth; confirmed

Capro-benzene spread improved markedly

Supported

USD 512 → USD 849 per MT (+66%); brightest segment spot

Overall profitability sustained through agility and pricing actions

Overstated

OPM 3.0%, NPM 4.1%; both compressed YoY; profitability not sustained

What changed on this call

Fertilizer margin collapse acknowledged. In the prior quarter's guidance, management expressed confidence that government support (revised NBS subsidy rates) would protect fertilizer margins. This quarter, management confronted a 92% EBIT crater in that very segment, due to raw material shocks that outpaced any subsidy benefit. This is no longer forward-looking optimism — it is backward-looking reality.

Subsidy dependency made explicit. In prior calls, subsidy support was discussed as a structural feature. On this call, CFO S.K. Bajpai stated with striking clarity: 'The subsidy is very important because whatever margins are coming, it is from subsidy. If the subsidy goes out, then there is no margin in any of the fertilizers.' Fertilizer segment margins are now at zero without subsidy.

Capex acceleration. The Sikka PA/SA (phosphoric acid/sulfuric acid) project, alluded to in prior calls, is now finalized. EPC contract awarded. ₹3,000 Crore capex over 30–33 months. Target: 20% margin, 50% captive consumption of DAP/NPK feedstock. This is a structural shift — moving from raw-material-cost-taker to supplier — but the timeline offers no near-term relief.

Capro-benzene moderation flagged. Management warned that the current capro-benzene spread of USD 849/MT is unsustainable and expected to moderate in Q3 as regional supply normalizes. IP segment EBIT is the only bright spot; a 20–30% compression in that spread could wipe out ₹10–15 Crore and turn it from a bright spot into a warning.

The bull-bear ledger

  • Record revenue (₹4,741 Cr) shows demand resilience despite inventory glut

  • Industrial segment 30% sales growth and ₹66 Cr EBIT — structural diversification working

  • Capex execution strong: Sikka PA/SA EPC awarded, C-Train modification commissioned Oct 2026

  • Solar power efficiency ₹20–25 Cr/quarter — operational cost-cutting live

  • Fertilizer EBIT down 92% despite 55% revenue growth — margins completely broken

  • Profitability now entirely subsidy-dependent; no announcement yet; cliff unresolved

  • Capro-benzene spread expected to moderate Q3; IP EBIT at risk

  • Fertilizer demand headwinds: inventory at 3-year high, weak monsoon, weak southern demand

  • ₹3,400 Cr subsidy receivable pending; working capital drag continues

  • Capex timeline (30–33 months) leaves company vulnerable to subsidy cliff in interim

Risks, ranked by concern to holders

Key risks to position sizing and timing

NBS subsidy rates not announced; fertilizer margins unknown through H2 FY27

HIGH

Fertilizer EBIT is ₹17 Cr (vs ₹224 Cr prior year). Management admits zero margin without subsidy. Any rate cut will trigger further profit compression. Material risk to full-year P&L.

Raw material cost volatility persists; no hedging disclosed

HIGH

Sulfur +327%, natural gas +62% this quarter. Geopolitical tensions persist. Sikka capex (30+ months away) is the only structural hedge; interim quarters remain exposed.

Capro-benzene spread moderation expected Q3 as regional supply normalizes

MEDIUM

Current spread USD 849/MT is unsustainable. IP EBIT (₹66 Cr) is 33% of consolidated. A 20–30% compression could wipe out ₹10–15 Cr, negating industrial strength and triggering Q3 miss.

Fertilizer demand weakness: inventory at 3-year high, monsoon subdued, southern India weak

MEDIUM

Volume down 6% YoY despite price-driven sales growth. Rabi season entering with highest 3-year inventory levels. Market share and margin pressure likely Q3–Q4.

Geopolitical tensions: supply chain disruptions persist

MEDIUM

Raw materials (sulfur, phosphoric acid, rock) globally sourced. Company sustained uninterrupted Q2 operations, but any escalation affects cost structure. No hedging mentioned.

How the street is positioned

Post-result price action tells a cautious story. GSFC announced Q2 results on November 02. The stock fell 0.31% on day 1, then recovered +3.61% by day 3. The recovery suggests institutional digestion rather than conviction: the market absorbed the profit miss, factored in the industrial offset and capex upside, and took a small step higher. But that bounce has not sustained; the stock now trades at ₹139.4, still near post-result lows, indicating skepticism of near-term earnings recovery.

Valuation context: A 56% drawdown from all-time high. The stock's all-time high was ₹314.71. Today it trades at ₹139.4 — a 55.71% drawdown. This reflects repricing of the fertilizer business from a high-margin commodity play to a subsidy-dependent utility with minimal pricing power. The stock trades below its 20-day (₹141.02), 50-day (₹149.46), and 200-day (₹161.39) moving averages, confirming a downtrend. RSI at 43.5 is neutral — neither oversold nor overbought — suggesting the market is still pricing in risk.

Institutional flows: Stable but not accumulating. FII ownership stands at 12.36% (up 0.01pp sequentially), DII at 7.33% (up 0.02pp). Promoter at 37.84% (unchanged). These are negligible quarter-on-quarter moves — no aggressive institutional accumulation on the dip, no panic selling either. Institutional indifference is telling: until the subsidy cliff is resolved, large investors are sitting on their hands rather than backing a turnaround thesis.

Volume trend: Normal. No spike in trading volume, no evidence of activist demand or distribution. This is a stock the market has already repriced; it now waits for news (subsidy announcement, capex milestones, Q3 capro-benzene trend) rather than trading on momentum.

What to watch next

Three concrete things that resolve the debate
  • 1 · NBS subsidy rate announcement (October–March 2027)

    The pivot. If rates support ≥10% fertilizer margins, Q3–H2 earnings stabilize and the stock re-rates higher. If rates are cut, delayed, or insufficient, fertilizer EBIT remains in crisis and the stock likely retraces toward ₹130–135. This is the binary that matters most.

  • 2 · Capro-benzene spread trend in Q3 FY27

    IP segment EBIT is the only consolidation bright spot. Track Q3 release for IP EBIT: if it holds >₹60 Cr, the industrial offset remains credible. If it falls below ₹50 Cr, the case for holding deteriorates.

  • 3 · Sikka PA/SA capex progress and first cost reductions

    The long-term story. Track quarterly EPC execution updates (% complete, cost overruns, supply delays). More immediately, watch for pilot cost-reduction data from in-house inputs post-commissioning (33 months out). Any capex delay or margin miss resets the structural upside timeline.

GSFC delivered record Q2 revenue but suffered a 38% profit decline, unmasking a fertilizer margin crisis now entirely subsidy-dependent. The industrial segment provides offset, but it is not large enough and is vulnerable to normal commodity moderation. The capex story (Sikka PA/SA) is genuinely transformative, but 30–33 months away offers no near-term relief. Until government subsidy rates are announced and prove adequate, this is a HOLD. The market has fairly repriced the stock at ₹139.4. The number to track from here is fertilizer EBIT in Q3 — whether subsidy support allows recovery or whether the crisis extends into H2.

Informational and educational content only. Not investment advice.